CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 80 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $180,830 | +60.1% | 21,553 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $112,938 | -3.5% | 21,553 | +0.6% | 0.00% | 0.0% |
| Q4 2019 | $116,975 | +48.4% | 21,424 | +32.3% | 0.00% | +100.0% |
| Q3 2019 | $78,850 | -36.6% | 16,191 | -9.8% | 0.00% | -50.0% |
| Q2 2019 | $124,449 | +21.5% | 17,958 | +21.8% | 0.00% | 0.0% |
| Q1 2019 | $102,450 | +3.4% | 14,741 | -13.2% | 0.00% | 0.0% |
| Q4 2018 | $99,122 | -22.6% | 16,973 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $128,146 | -99.9% | 16,973 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $85,713,000 | -17.2% | 16,973 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $103,536,000 | +100420.4% | 16,973 | +16.7% | 0.00% | 0.0% |
| Q4 2017 | $103,000 | -56.7% | 14,550 | -56.3% | 0.00% | 0.0% |
| Q3 2017 | $238,000 | +12.8% | 33,287 | -0.6% | 0.00% | 0.0% |
| Q2 2017 | $211,000 | – | 33,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,563,925 | $16,717,000 | 29.31% |
| Cormorant Asset Management, LP | 2,000,000 | $13,580,000 | 1.50% |
| Perceptive Advisors | 2,701,023 | $18,339,000 | 1.18% |
| Fosun International Ltd | 700,071 | $4,753,000 | 0.53% |
| Ghost Tree Capital, LLC | 200,000 | $1,358,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 81,302 | $552,000 | 0.21% |
| IFP Advisors, Inc | 300,000 | $2,037,000 | 0.11% |
| CONNING INC. | 351,280 | $2,385,000 | 0.10% |
| WOODSTOCK CORP | 39,931 | $271,000 | 0.06% |
| Yellowstone Partners, LLC | 15,944 | $108,000 | 0.04% |